Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021

SELL
$1.89 - $2.96 $2.76 Million - $4.32 Million
-1,458,333 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$0.65 - $1.94 $947,916 - $2.83 Million
1,458,333 New
1,458,333 $2.83 Million
Q3 2019

Nov 14, 2019

SELL
$0.46 - $1.29 $195,500 - $548,250
-425,000 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$1.1 - $1.76 $467,500 - $748,000
425,000 New
425,000 $544,000

Others Institutions Holding VTGN

About VistaGen Therapeutics, Inc.


  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $623M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.